Abstract: The present invention relates to a method of producing drimenol and/or drimenol derivatives by contacting at least one polypeptide with farnesyl diphosphate. The method may be performed in vitro or in vivo. The present invention also provides amino acid sequences of polypeptides useful in the method of the invention and nucleic acid encoding the polypeptides of the invention. The method further provides host cells or organisms genetically modified to express the polypeptides of the invention and useful to produce drimenol and/or drimenol derivatives.

Abstract: The present document provides a method, a device and a system for implementing a local gateway service. Wherein the method includes: adding, by a first connection device, a second connection device for a terminal (300); interacting collocated local gateway address information between the first connection device and the second connection device (301); and reporting, by the first connection device, determined collocated local gateway address information to a core network, and using, by the core network, the collocated local gateway address information to perform the local gateway service (302). Through the technical solution provided by the embodiment of the present document, the core network obtains the collocated local gateway address information, and the local gateway service is implemented aiming at a dual-connection service scenario.

Abstract: The present invention relates to an oxopicolinamide derivative, a preparation method therefor and the pharmaceutical use thereof. In particular, the present invention relates to an oxopicolinamide derivative as shown in the general formula (AI), a preparation method therefor and a pharmaceutical composition comprising the derivative, and to the use thereof as a therapeutic agent, in particular as an inhibitor of blood coagulation factor XIa (Factor XIa, FXIa for short) and the use thereof in the preparation of a drug for treating diseases such as thromboembolism, wherein the definition of each substituent in the general formula (AI) is the same as defined in the description.

Abstract: The present invention provides a phenylpropanamide derivative as represented by formula (I), a manufacturing method of the derivative, application of the derivative as a ?-opioid receptor (KOR) agonist, and application of the derivative for manufacturing a pharmaceutical product for treating and/or preventing pain or a pain-related disease.

Abstract: A method for information interaction under small cell deployment, includes: a mobility management entity re-selecting a serving gateway for a user equipment; the mobility management entity sending an evolved radio access bearer (ERAB) modification message to a master evolved node B to which the user equipment accesses, wherein the ERAB modification message carries new ERAB transport information. The embodiments of the present document further disclose an evolved node B working as a master evolve node B under small cell deployment.

Abstract: Disclosed are an information interaction method and system and a base station. The information interaction method of the present disclosure is applied to a dual connectivity data offloading technology in a Long Term Evolution (LTE) system, and specifically includes that a sending party sends information related to processing user plane data to a corresponding receiving party in batches according to a preset rule.

Abstract: An information entering method for a terminal is provided. The terminal comprises a fingerprint sensor and a motion sensor. The terminal displays an interface, which comprises an information entering box. The terminal collects a first fingerprint using the fingerprint sensor. The terminal obtains motion data of the terminal collected by the motion sensor in a first time period after the terminal determines that the first fingerprint matches a preset fingerprint. The terminal obtains information corresponding to the first fingerprint and the motion data, or obtaining information corresponding to the motion data. The terminal enters-the obtained information into the information entering box.

Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for the treatment of lysine (K)-specific demethylase 1A (LSD1)-mediated diseases or disorders: wherein R1, R2, R3, R4, R5, and R6 are as defined herein.

Abstract: The present invention discloses a method of producing drimenol and/or drimenol derivatives by contacting a polypeptide with farnesyl pyrophosphate. Also provided is an amino acid sequence of a polypeptide useful in the methods of the invention and nucleic acid encoding the polypeptides of the invention. The method further provides host cells or organisms genetically modified to express the polypeptides of the invention and useful to produce drimenol and/or drimenol derivatives.

Abstract: A touch structure includes a first touch electrode and a second touch electrode. The first touch electrode includes multiple ring-shaped electrodes, which are concentrically arranged around a center. The second touch electrode is electrically insulated from the first touch electrode, and includes multiple first block-shaped electrode and multiple second block-shaped electrodes. An area of each of the first block-shaped electrodes is A1, an area of each of the second block-shaped electrodes is A2, and A1 ?A 2. The first block-shaped electrodes are arranged from the center toward a direction away from the center and are electrically connected to each other to form a first electrode string. The second block-shaped electrodes are arranged from the center toward a direction away from the center and are electrically connected to each other to form a second electrode string. The first electrode string and the second electrode string are electrically connected.

Abstract: An ultrathin glass article has a thickness of less than or equal to 0.5 mm. The glass has a low TTV and a large threshold diffusivity. The glass has a working point T4 of more than 1100° C. and a linear thermal expansion coefficient CTE of more than 6*10?6/° C. in the temperature range between 25° C. and 300° C. A method for producing the article as well as the use of the article is also provided. The glass article can be chemically strengthened and forms surface compressive stress layers on surfaces and center tension layer in the center. The toughened ultrathin glass sheet is more flexible and has extraordinary thermal shock resistance which makes it easier to handle for processing.

Abstract: A method for information interaction under small cell deployment, includes: a master evolved node B adding a candidate secondary evolved node B for a user equipment (S10); the master evolved node B interacting local home network information with the candidate secondary evolved node B via an inter-evolved node B interface (S20); the master evolved node B determining whether to use the candidate secondary evolved node B to provide the user equipment with a dual connectivity service (S30). The embodiments of the present document can provide a guarantee for selecting a standalone gateway to support a selected Internet Protocol (IP) traffic offload at local network (SIPTO@LN) service aiming at the dual connectivity service feature under small cell deployment.

Abstract: The invention describes a capacitive power transfer arrangement (1) for transferring power between a first electrical device (10) and a physically independent second electrical device (20), which power transfer arrangement (1) comprises a number of coupled capacitors (C1, C2), and wherein a coupled capacitor (C1, C2) comprises a first electrode (C110, C210), which first electrode (C110, C210) comprises a heatsink (H1, H2) thermally coupled to a heat dissipating component (Q, 14) of a power supply (12) of the first electrical device (10); a second electrode (C120, C220) realized in the second electrical device (20); and a dielectric layer (D) formed by a housing (16, 26) of at least one of the electrical devices (10, 20). The invention further describes a method of performing capacitive power transfer from a first electrical device (10) to a physically independent second electrical device (20); a driver (11) of an electrical device (10); and n electrical device (10) comprising such a driver (11).

Abstract: The present invention relates to a benzopiperidine derivative, a preparation method thereof and a medical use thereof. In particular, the present invention relates to a benzopiperidine derivative as shown by general formula (I), a preparation method thereof and a pharmaceutical composition containing the derivative, as well as a use thereof as an estrogen receptor modulator in the prevention and/or treatment of estrogen receptor-mediated or dependent diseases or conditions. Preferably, the disease is breast cancer. The substituents in the general formula (I) are the same as those defined in the description.

Abstract: A method and a base station for processing an SIPTO (Selected IP Traffic Offload) connection, the method includes: when a terminal is handed over from a source SeNB (Secondary eNB) to a destination SeNB, receiving, by an MeNB (Master eNB), an interface message from the destination SeNB (11), herein the source SeNB supports a collocated L-GW (Local Gateway); and when a handover success acknowledgement message sent by the destination SeNB is received, triggering, by the MeNB, the source SeNB to notify the L-GW to release an SIPTO@LN (Selected IP Traffic Offload at Local Network) connection (12). Through the embodiments of the present document, the release of the SIPTO@LN connection in a collocated L-GW scenario under a small base station environment can be effectively implemented.

Abstract: The present invention relates to an oxa spiro derivative, a preparation method therefor, and applications thereof in medicines. Particularly, the present invention relates to an oxa spiro derivative represented by formula (I), a preparation method therefor, and a pharmaceutical composition comprising the derivative, applications thereof as an MOR receptor agonist, and applications in the preparation of drugs for treating and/or preventing pains and pains-related diseases. Substituent groups in the formula (I) are same as definitions in the specification.

Abstract: Disclosed is a lighting arrangement (10) comprising a lighting device (20) having an adjustable luminous output; a control arrangement (30) communicatively coupled to the dimmable lighting device including a controller (39) adapted to adjust the luminous output of the lighting device a data storage device accessible by the controller storing calibration data for a light measurement device of a mobile communication device, the calibration data being a function of a distance between the mobile communication device and the lighting device and a communication module (31) communicatively coupled to the controller, wherein the control arrangement is adapted to control the lighting device such that the lighting device produces a predefined luminous output; receive a luminous output measurement from the mobile communication device at an unknown distance from the lighting device; retrieve distance information regarding the distance between the mobile communication device and the lighting device from the calibration da

Abstract: A chemically toughened ultrathin glass is provided. The glass has a thickness less than 500 ?m and a surface compressive layer having a depth of at most 30 ?m. The toughened ultrathin glass sheet is more flexible and has extraordinary thermal shock resistance with the glass being easier to handle for processing.

Abstract: The present invention relates to a method of producing drimenol and/or drimenol derivatives by contacting at least one polypeptide with farnesyl diphosphate. The method may be performed in vitro or in vivo. The present invention also provides amino acid sequences of polypeptides useful in the method of the invention and nucleic acid encoding the polypeptides of the invention. The method further provides host cells or organisms genetically modified to express the polypeptides of the invention and useful to produce drimenol and/or drimenol derivatives.

Abstract: A three-dimensional image displaying system includes a drive controller, a display panel, a refraction variable part, and a lens. The drive controller is configured to display a slice image of a stereoscopic object on the display panel according to a set sequence and control, according to a depth of the slice image in the stereoscopic object, refraction intensity of the refraction variable part for a light ray projected by the display panel when the slice image is displayed on the display panel. A time required for successively displaying all slice images, which are of the stereoscopic object to be imaged and are perpendicular to one visual axis, on the display panel at a time according to the set sequence is less than a time of persistence of vision. The display panel is configured to display the slice image under control of the drive controller. The lens is configured to perform imaging according to a light ray refracted by the refraction variable part.